Back to REGN
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC → REGN
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC REGN Position History
Regeneron Pharmaceuticals, Inc. • Healthcare
Quarters held
5
Latest value
$19.6M
Q3 2026
Peak value
$21M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $10.3M |
| Q4 2025 | $17.5M |
| Q1 2026 | $21M |
| Q2 2026 | $15.9M |
| Q3 2026 | $19.6M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $19.6M | 37.2K | — | — |
| Q2 2026 | $15.9M | 33.9K | — | — |
| Q1 2026 | $21M | 37.6K | — | — |
| Q4 2025 | $17.5M | 22.4K | — | — |
| Q3 2025 | $10.3M | 17.6K | — | — |
Other funds holding REGN
$6.2B
$5.7B
$5.2B
$5.1B
$4.7B
$4.7B
$4.5B
$4.3B